Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIa Study Assessing QBS72S For Treating Brain Metastases

NCT05305365 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT05305365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05305365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIa Study Assessing QBS72S For Treating Brain Metastases
Lead sponsor
Stanford University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 16, 2022
Completion date
December 31, 2027
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases, breast cancer, leptomeningeal disease, lmd, lung cancer